SOURCE: Gilead Sciences

DESCRIPTION:

What goes into making innovative new medicines? In the second installment of our “Inside the Innovation” series, Gilead’s Ken Kent and Monica Tijerina discuss our patient-focused approach to developing medicines and the importance of including diverse voices throughout the process.

Originally published by Gilead Sciences

Tweet me: .@GileadSciences Ken Kent and Monica Tijerina discuss a patient-focused approach to developing medicines and the importance of including diverse voices throughout the process: https://bit.ly/3sbiMrx

KEYWORDS: NYSE: GILD, Gilead Sciences